73 results
Page 2 of 4
S-3
EX-1.2
p83jdeon
1 Jul 22
Shelf registration
4:13pm
DEF 14A
lf8tv9ykrepfzjt
28 Apr 22
Definitive proxy
8:36am
424B3
fbq9u5so 5wk10ra
31 Mar 22
Prospectus supplement
11:42am
POS AM
ck0 y7bj4d
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
8-K
EX-99.1
r58jl czp
25 Mar 22
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
8:22am
424B3
EX-99.1
rm091vc6y5 bvf22ci
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.1
fixqz zgg4c4en64j27d
25 Feb 22
Regulation FD Disclosure
8:38am
424B3
EX-99
dhtf0wyfhqksj9qj1n
1 Dec 21
Prospectus supplement
8:25am
8-K
363cedu
1 Dec 21
Departure of Directors or Certain Officers
8:14am
8-K
EX-99.1
u4e li4u6243c4hz1iuc
19 Nov 21
Regulation FD Disclosure
8:09am
424B3
7yblfbjqvv4qokpc
28 Sep 21
Prospectus supplement
9:07am
8-K
EX-99.1
wm9y 9qr8r9e9mzr2
28 Sep 21
Entry into a Material Definitive Agreement
8:53am
424B3
t47co
5 Aug 21
Prospectus supplement
4:26pm
424B3
ziz652q502n456 3n
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.7
bzpwv6zm28697u
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm